Clinical implications of pleural effusions in ovarian cancer
暂无分享,去创建一个
J. M. Porcel | D. Chi | José M Porcel | John P Diaz | Dennis S Chi | J. Diaz | J. Porcel
[1] G. Györy,et al. Beitrag zum Meigs-Syndrom , 1957 .
[2] A. Vermeulen,et al. [Meig's syndrome]. , 1957, Belgisch tijdschrift voor geneeskunde.
[3] J. Schubert. [Treatment of ovarian cancer]. , 1961, Ceskoslovenska gynekologie.
[4] B. Chakrabarty. Pseudo-Meig's syndrome. , 1968, Journal of the Indian Medical Association.
[5] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[6] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[7] J. Herndon,et al. Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. , 2002, AJR. American journal of roentgenology.
[8] R. Mannel,et al. Ascites as a predictor of ovarian malignancy. , 2002, Gynecologic oncology.
[9] S. Eisenkop. Thoracoscopy for the management of advanced epithelial ovarian cancer--a preliminary report. , 2002, Gynecologic oncology.
[10] E. Trimble,et al. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Levine,et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma , 2005, Cancer.
[12] M. Akıncı,et al. A long surviving case of Pseudomeigs' syndrome caused by Krukenberg tumor of the stomach. , 2005, Japanese journal of clinical oncology.
[13] R. Burger,et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. , 2006, The New England journal of medicine.
[14] R. Barakat,et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. , 2006, Gynecologic oncology.
[15] Osama M. Al-Agha,et al. An in-depth look at Krukenberg tumor: an overview. , 2006, Archives of pathology & laboratory medicine.
[16] R. Barakat,et al. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. , 2007, Gynecologic oncology.
[17] R. Younes,et al. Do Concomitant Ascites Influence the Effectiveness of Palliative Surgical Management of Pleural Effusion in Patients with Malignancies? , 2009, World Journal of Surgery.
[18] L. Cellerin,et al. Pleurésies malignes révélatrices d’un cancer : comparaison des étiologies avec les pleurésies métastatiques d’un cancer connu , 2008 .
[19] M. Riquet,et al. Role of Video-Assisted Thoracoscopy in Patients With Ovarian Cancer and Pleural Effusion , 2009, International Journal of Gynecologic Cancer.
[20] R. Morice,et al. Medical thoracoscopy , 2009, Current opinion in pulmonary medicine.
[21] D. Levine,et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. , 2009, Gynecologic oncology.
[22] H. Nishi,et al. Pilot Study on Transdiaphragmatic Thoracoscopic-Assisted Pleural Biopsy and Intrathoracic Washing Cytology for Stage IIIc Ovarian Cancer With Diaphragmatic Metastases , 2009, International Journal of Gynecologic Cancer.
[23] S. Aishima,et al. Pseudo-Meigs’ syndrome associated with breast cancer metastasis to both ovaries: Report of a case , 2010, Surgery Today.
[24] W. Cliby,et al. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment. , 2009, Gynecologic oncology.
[25] G. Scambia,et al. Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. , 2010, Gynecologic oncology.
[26] A. Marchevsky,et al. Evidence‐based guidelines to optimize the selection of antibody panels in cytopathology: Pleural effusions with malignant epithelioid cells , 2009, Diagnostic cytopathology.
[27] R. Barakat,et al. Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients. , 2010, Gynecologic oncology.
[28] Richard G. Moore,et al. Current clinical use of biomarkers for epithelial ovarian cancer , 2010, Current opinion in oncology.
[29] Seung Hyup Kim,et al. The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer. , 2010, European journal of radiology.
[30] Jacobus Pfisterer,et al. Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease , 2010, Annals of Surgical Oncology.
[31] A. Kleontas,et al. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases , 2010, Journal of cardiothoracic surgery.
[32] C. Haie-meder,et al. Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer. , 2010, Journal of the American College of Surgeons.
[33] A. Berchuck,et al. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. , 2010, Obstetrics and Gynecology.
[34] G. Kenter,et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. , 2010, The New England journal of medicine.
[35] A. Tarn,et al. Biochemical analysis of ascitic (peritoneal) fluid: what should we measure? , 2010, Annals of clinical biochemistry.
[36] K. Hanazaki,et al. Clinical experience of Pseudo-Meigs' Syndrome due to colon cancer. , 2011, World journal of gastroenterology.
[37] Barry Rosen,et al. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. , 2011, Gynecologic oncology.
[38] R. Molina,et al. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. , 2011, Clinical chemistry.
[39] R. Rouzier,et al. Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[40] M. Eijkemans,et al. Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer. , 2011, Anticancer research.
[41] J. Schorge,et al. Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer , 2012, Annals of Surgical Oncology.
[42] H. Hricak,et al. Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. , 2011, Radiology.
[43] J. Schorge,et al. Cytoreductive surgery for advanced ovarian cancer: quo vadis? , 2011, Oncology.
[44] M. Jordá,et al. Effusion Cytology: A Practical Guide to Cancer Diagnosis , 2011 .
[45] D. Chi,et al. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. , 2011, Gynecologic oncology.
[46] D. Armstrong,et al. Recent progress in the diagnosis and treatment of ovarian cancer , 2011, CA: a cancer journal for clinicians.
[47] A. Jemal,et al. Global Cancer Statistics , 2011 .
[48] J. M. Porcel,et al. Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions , 2011, Lung.
[49] HiromichiMaeda,et al. Clinical experience of Pseudo-Meigs' Syndrome due to colon cancer , 2011 .
[50] J. Dungan,et al. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer , 2011 .
[51] A. Bryant,et al. Optimal primary surgical treatment for advanced epithelial ovarian cancer. , 2011, The Cochrane database of systematic reviews.
[52] F. Landoni,et al. Diaphragmatic Surgery During Primary Cytoreduction for Advanced Ovarian Cancer: Peritoneal Stripping Versus Diaphragmatic Resection , 2011, International Journal of Gynecologic Cancer.
[53] A. Krishan,et al. Comprar Effusion Cytology. A Practical Guide To Cancer Diagnosis | Krishan, A. | 9781933864655 | Demos Medical Publishing , 2011 .
[54] P. Neven,et al. Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patients. , 2011, European journal of cancer.
[55] H. Hricak,et al. Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery , 2011, Journal of gynecologic oncology.
[56] V. Zagonel,et al. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis , 2012, Cancer Chemotherapy and Pharmacology.
[57] A. Al-Niaimi,et al. Epithelial ovarian cancer. , 2012, Obstetrics and gynecology clinics of North America.
[58] R. Cerfolio,et al. Outcomes of patients with gynecologic malignancies undergoing video-assisted thoracoscopic surgery (VATS) and pleurodesis for malignant pleural effusion. , 2011, Gynecologic oncology.
[59] J. M. Porcel,et al. Solving the Light's criteria misclassification rate of cardiac and hepatic transudates , 2012, Respirology.
[60] Jeffrey M. Fowler,et al. Incorporation of bevacizumab in the primary treatment of ovarian cancer , 2012 .
[61] N. Spirtos,et al. Upper abdominal cytoreduction and thoracoscopy for advanced epithelial ovarian cancer: unanswered questions and the impact on treatment , 2012, BJOG : an international journal of obstetrics and gynaecology.